10208 Results

People

  1. Gonen
    Gonen
  2. Vickers
    Vickers
  3. Panageas
    Panageas
  4. Patil
    Patil
  5. Schultz
    Schultz
  6. Giralt
    Giralt
  7. Zhang
    Zhang
  8. Jarnagin
    Jarnagin
  9. Heller
    Heller
  10. D'Angelica
    D'Angelica

Groups

  1. Epidemiology and Biostatistics (10208)
  2. Biostatistics Service (6565)
  3. Department of Medicine (4908)
  4. Population Sciences Research Program (4867)
  5. Surgery (3680)
  6. Survivorship Research (3598)
  7. Solid Tumor Oncology Division (3294)
  8. GSK Faculty (2808)
  9. Center for Pancreatic Cancer Research (2495)
  10. Health Outcomes Research Group (2069)
  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (6429)
  2. Meeting Abstract (3246)
  3. Editorial (116)
  4. Review (93)
  5. Research Letter (80)
  6. Correspondence (77)
  7. Conference Paper (54)
  8. Miscellaneous (52)
  9. Book Section (43)
  10. Guidelines (13)
  11. Book Whole (5)
Groups
  1. Epidemiology and Biostatistics (10208)
  2. Biostatistics Service (6565)
  3. Department of Medicine (4908)
  4. Population Sciences Research Program (4867)
  5. Surgery (3680)
  6. Survivorship Research (3598)

More Groups

People
  1. Mithat Gonen (1028)
  2. Andrew Vickers (880)
  3. Sean Devlin (601)
  4. Katherine Panageas (512)
  5. Sujata Patil (511)
  6. Nikolaus Schultz (486)

More People

Years
  1. 2025 (210)
  2. 2024 (622)
  3. 2023 (692)
  4. 2022 (732)
  5. 2021 (610)
  6. 2020 (625)

More Years

Publications
  1. Journal of Clinical Oncology (1374)
  2. Blood (534)
  3. Annals of Surgical Oncology (462)
  4. Cancer Research (274)
  5. International Journal of Radiation Oncology, Biology, Physics (258)
  6. Clinical Cancer Research (250)

More Publications

Publishers
  1. American Society of Clinical Oncology (1487)
  2. Elsevier Inc. (1206)
  3. Springer (925)
  4. American Association for Cancer Research (761)
  5. Elsevier Science, Inc. (685)
  6. American Society of Hematology (601)

More Publishers

Results (10208)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • mTOR inhibitor therapy for metastatic sarcomatoid clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Bastos, D. A.; Voss, M. H.; Karlo, C.; Ajeti, A.; Patil, S.; Feldman, D. R.; Molina, A. M.; Motzer, R. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Risk assessment for severe hypocalcemia requiring hospitalization with denosumab
    Meeting Abstract

    Autio, K. A.; Farooki, A.; Glezerman, I.; Chan, A.; Barr, H. C.; Seyboth, B. M.; Schneider, C. W.; Heller, G.; Scher, H. I.; Morris, M. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Exome sequencing of extreme phenotypes to identify variants predictive of response to chemotherapy in bladder cancer
    Meeting Abstract

    Alanee, S.; Shah, S.; Stratton, K. L.; Garcia-Grossman, I. R.; Zabor, E.; Ostrovnaya, I.; Joseph, V.; Pendse, D.; Bajorin, D. F.; Offit, K.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Peroxisome proliferator-activated receptor gamma (PPARG) gene amplifications in urothelial carcinoma (UC)
    Meeting Abstract

    Bambury, R. M.; Iyer, G.; Riester, M.; Werner, L.; Schultz, N.; Stack, E. C.; Park, R.; Loda, M.; Ostrovnaya, I.; Kantoff, P. W.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Comparison of the characteristics and clinical course of 677 patients with metastatic lung cancers with mutations in KRAS codons 12 and 13
    Meeting Abstract

    Yu, H. A.; Sima, C. S.; Shen, R. L.; Kass, S. L.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • TBCRC 019: An open label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel (nab-PAC) with or without the anti-death receptor 5 (DR5) monoclonal antibody tigatuzumab (TIG) in patients with metastatic triple negative breast cancer (TNBC)
    Meeting Abstract

    Vakiavas, C.; Abramson, V. G.; Lin, N. U.; Liu, M. C.; Rugo, H. S.; Nanda, R.; Storniolo, A. M.; Traina, T. A.; Li, Y.; Patil, S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Sera cytokine levels to predict survival in men with progressive castration-resistant prostate cancer
    Meeting Abstract

    Subudhi, S. K.; Heller, G.; Danila, D. C.; Anand, A.; Lacuna, K. P.; Samoila, A.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prognostic implication of KIT mutations in melanoma
    Meeting Abstract

    Roth, K. G.; Zabor, E. C.; Colgan, M. N.; Wolchok, J. D.; Chapman, P. B.; Schwartz, G. K.; Panageas, K. S.; Carvajal, R. D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II clinical and translational study of MK-2206 in patients with metastatic neuroendocrine tumors (NETs)
    Meeting Abstract

    Reidy, D. L.; Pietanza, M. C.; Segal, M.; Capanu, M.; Saltz, L.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save